Glycosphingolipids of normal and leukemic human leukocytes

Summary We have reviewed the studies on neutral glycosphingolipids and gangliosides of normal and leukemia human leukocytes. In this review, we examine (a) the glycosphingolipid composition of various leukocyte populations, (b) the differences in glycosphingolipids found among subsets of these cells, (c) the possible use of these compounds as markers of differentiation, and (d) the changes in glycosphingolipid composition that occur with leukemogenesis.     

Adenylate cyclase activity in normal and leukemic human leukocytes as determined by a radioimmunoassay for cyclic AMP

Adenylate cyclase in human leukocytes is a labile enzyme easily damaged during rupture. Homogenization in a glass homogenizer in the presence of 0.25 M sucrose preceded by swelling in the slightly hypotonic media retained the cyclase activity. Other conditions such as sonication or homogenization in the absence of sucrose resulted in a variable loss of activity. The cyclase activity was determined by a radioimmunoassay which, with some modifications, proved more sensitive than the labelled ATP assay method. Adenylate cyclase from lymphocytes of patients with chronic lymphatic leukemia exhibited an altered response to prostaglandins E₁, E₂ and F_2α when compared with cyclase from normal human lymphocytes.     

Thymine 7-hydroxylase activity in normal and leukemic leukocytes

Thymine 7-hydroxylase activity was detected in normal and leukemic leukocytes of Fischer 344 rats as witnessed by the conversion of thymine-2-¹⁴C to 5-hydroxymethyluracil. All the enzyme activity was found inside the cells, but occasionally low levels of activity were recovered from the plasma. The catalysis of the reaction was stimulated by ascorbic acid, α-ketoglutaric acid and Fe²⁺. Leukemic cells produced up to eight times as much product as normal leukocytes.     

Lectin affinity fractionation of asparagine-linked oligosaccharides from normal human and chronic leukemic leukocytes

Asparagine-linked oligosaccharides were isolated from normal and chronic leukemic leukocytes (normal neutrophils, normal lymphocytes, chronic myeloid, chronic lymphoid and hairy cell leukemic leukocytes) and analyzed by sequential lectin affinity column chromatography. The neutral and sialylated glycopeptides ranged in size from 1,800 to 4,000 da. on gel filtration. Sequential lectin affinity analysis was then used to fractionate the Asn-oligosaccharides into major structural classes of high mannose, hybrid, and bi-, tri- and tetraantennary complex structures. Using lectins of well defined specificity, the sequential chromatography provided a satisfactory means of assessing the overall glycopeptide profiles of the different leukocyte types. Results from 10 patient samples show that alterations in leukocyte Asn-oligosaccharides occur during leukemogenesis. Most notable was an average twofold increase in the relative amount of high mannose glycopeptides compared to complex glycopeptides for the leukemic cells. High mannose glycopeptides comprised 8.6 percent of the total lectin-adherent glycopeptides from leukemics, and 4.2 percent in the normals. In addition, carbohydrate analysis has revealed that the total amount of neutral hexose was markedly decreased in all leukemic samples. Leukemics ranged from 10.5 to 18.8, while normals ranged from 24.2 to 49.2 nanomole of hexose per 100 micrograms protein. The sialic acid content of the leukemic glycopeptides was relatively unchanged from that of normals, resulting in an apparent increase in the sialic acid: hexose ratio for all leukemic glycopeptides. The results suggest that in the leukemic cells, high mannose structures constitute a larger proportion of the total Asn-linked oligosaccharides, while the overall level of protein glycosylation is decreased. Complex multiantennary glycopeptides, when synthesized, tended to be more fully sialylated than their normal counterparts.     

Lysophosphatidylserine stimulates leukemic cells but not normal leukocytes

In this study, we observed that lysophosphatidylserine (LPS) stimulated intracellular calcium ([Ca(2+)](i)) increase in leukemic cells but not in normal human peripheral blood mononuclear cells. LPS also stimulated [Ca(2+)](i) increase in human leukemic THP-1 cells. LPS-stimulated [Ca(2+)](i) increase was inhibited by U-73122 but not by U-73343. LPS also stimulated inositol phosphates formation in THP-1 cells, suggesting that LPS stimulates calcium signaling via phospholipase C activation. Moreover, pertussis toxin (PTX) completely inhibited [Ca(2+)](i) increase by LPS, indicating the activation of PTX-sensitive G-proteins. We also found that LPS-induced [Ca(2+)](i) increase was completely inhibited by suramin, suggesting G-protein coupled receptor activation. Since LPS specifically stimulates PTX-sensitive G-proteins, phospholipase C-dependent [Ca(2+)](i) increase in leukemic cells but not normal peripheral blood leukocytes, LPS receptor may be associated with leukemia.     

Expression of human IMP dehydrogenase types I and II in Escherichia coli and distribution in human normal lymphocytes and leukemic cell lines.

Two distinct cDNAs encoding proteins with 84% sequence identity have been isolated for human IMP dehydrogenase (EC 1.1.1.205) (Natsumeda, Y., Ohno, S., Kawasaki, H., Konno, Y., Weber, G., and Suzuki, K. (1990) J. Biol. Chem. 265, 5292-5295), an important target in antileukemic chemotherapy. We constructed expression plasmids containing these cDNAs in full length with pUC plasmids and produced lacZ'-IMP dehydrogenase fusion proteins in Escherichia coli. Both synthesized proteins exhibited IMP dehydrogenase activity and were partially separated from endogenous E. coli IMP dehydrogenase. By injecting the fusion proteins into mice we generated a polyclonal antibody specific to type I IMP dehydrogenase and an antibody which reacted with both types. Immunoblot analysis revealed that the total amounts of types I and II enzymes increased in human leukemic cell lines K562 and HL-60 in agreement with the increase in IMP dehydrogenase activity to 7.8- and 9.4-fold, respectively, above that of normal lymphocytes. The extent of expression of type I IMP dehydrogenase was similar in these cells, however, indicating that the increase in IMP dehydrogenase amount in leukemic cells was due to specific up-regulation of type II enzyme. Northern blot analysis also showed specific and predominant expression of type II in the leukemic cells. Thus, de novo GTP biosynthesis may be controlled differently in normal and neoplastic cells by different IMP dehydrogenase molecular species.     

Protein phosphorylation of lysosomal arylsulfatase B in normal and leukemic leukocytes

An acidic variant form of arylsulfatase B from normal leukocytes and chronic myelogenous leukemia (CML) leukocytes was found to be phosphorylated at its serine and threonine residues through in vivo phosphorylation with 32Pi. However, the predominant phosphorylation site was serine in normal cells, in contrast to threonine in CML cells. A cyclic AMP-dependent protein kinase was responsible for phosphorylation of the sulfatase of CML cells.